MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJuly 5, 2024
MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract…
MaaT PharmaJuly 5, 2024
MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033…
MaaT PharmaJuly 2, 2024
MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating…
MaaT PharmaJune 25, 2024
MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer Lyon, France, June 24th…
MaaT PharmaJune 24, 2024
• June 22-25, 2024 – International Human Microbiome Consortium (IHMC) Congress 2024
MaaT PharmaJune 11, 2024